Ruppin D C, Frydman M I, Lunzer M R
Med J Aust. 1982 May 15;1(10):421-4. doi: 10.5694/j.1326-5377.1982.tb132397.x.
Serum gamma-glutamyltransferase activity (GGT) has been measured in 150 patients with a variety of hepatobiliary disorders. GGT concentration was significantly higher in patients with "cholestatic" liver disease than in those with "hepatic" disorders, although there was considerable overlap. Measurement of GGT alone did not allow differentiation of intrahepatic cholestasis from extrahepatic cholestasis. However, GGT/serum bilirubin ratios were significantly higher in patients with intrahepatic cholestasis when compared with patients with extrahepatic biliary obstruction. Estimation of serum concentration of GGT appears to be a sensitive screening test both for alcohol consumption and for hepatobiliary disease. However, measurement of GGT concentration has only limited value in the differential diagnosis of hepatobiliary disease, although it may help in the differentiation of "hepatitic" and "cholestatic" liver disease.
已对150例患有各种肝胆疾病的患者进行了血清γ-谷氨酰转移酶活性(GGT)检测。尽管存在相当大的重叠,但“胆汁淤积性”肝病患者的GGT浓度显著高于“肝脏”疾病患者。仅测量GGT无法区分肝内胆汁淤积和肝外胆汁淤积。然而,与肝外胆管梗阻患者相比,肝内胆汁淤积患者的GGT/血清胆红素比值显著更高。GGT血清浓度的测定似乎是酒精摄入和肝胆疾病的敏感筛查试验。然而,GGT浓度的测量在肝胆疾病的鉴别诊断中价值有限,尽管它可能有助于区分“肝炎性”和“胆汁淤积性”肝病。